Atlas Trials

Expanded Access Program for Revumenib

Clinical trial NCT05918913 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT05918913
Sponsor
Syndax Pharmaceuticals
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Relapsed/Refractory Acute Leukemia

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.